Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 2921-2943
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.2921
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.2921
Figure 17 Peptide YY immunoreactivity (arrows) in the colon of a healthy subject and in a patient with irritable bowel syndrome.
A: Healthy subject; B: Patient with irritable bowel syndrome.
- Citation: El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943
- URL: https://www.wjgnet.com/1007-9327/full/v27/i22/2921.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i22.2921